Jeremy Mason

Jeremy Mason is an Assistant Professor of Research Urology at the University of Southern California. His research focuses on liquid biopsy technologies, mathematical oncology, and metastatic cancer progression modeling. He has pioneered work on circulating tumor cells (CTCs), oncosomes, and blood-based biomarkers for early cancer detection and treatment monitoring.

Key research areas include spatial analysis of metastatic patterns using machine learning, efficacy of blood filtration techniques for cancer patients, and longitudinal tracking of rare cancer events. His interdisciplinary approach integrates engineering, computational biology, and clinical oncology to develop non-invasive diagnostic tools.

Publications highlight advancements in pancreatic cancer filtration systems, brain metastasis distribution modeling, and liquid biopsy applications in urothelial and breast cancers. Ongoing work explores predictive analytics for treatment response and survival outcomes in metastatic diseases.